Ellagic Acid Induces DNA Damage and Apoptosis in Cancer Stem-like Cells and Overcomes Cisplatin Resistance
Open Access
- 5 December 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (50) , 48988-49000
Abstract
Cancer stem cells (CSCs) are responsible for chemoresistance and tumor relapse in many solid malignancies, including lung and ovarian cancer. Ellagic acid (EA), a natural polyphenol, exhibits anticancer effects on various human malignancies. However, its impact and mechanism of action on cancer stem-like cells (CSLCs) are only partially understood. In this study, we evaluated the therapeutic potential and underlying molecular mechanism of EA isolated from tropical mango against CSLCs. Herein, we observed that EA treatment reduces the stem-like phenotypes in cancer cells, thereby lowering the cell survival and self-renewal potential of ovarian and lung CSLCs. Additionally, EA treatment limits the populations of lung and ovarian CSLCs characterized by CD133+ and CD44+CD117+, respectively. A mechanistic investigation showed that EA treatment induces ROS generation by altering mitochondrial dynamics, causing changes in the levels of Drp1 and Mfn2, which lead to an increased level of accumulation of DNA damage and eventually trigger apoptosis in CSLCs. Moreover, pretreatment with EA sensitizes CSLCs to cisplatin treatment by enhancing DNA damage accumulation and impairing the DNA repair ability of the CSLCs. Furthermore, EA pretreatment significantly reduces cisplatin-induced mutation frequency and improves drug retention in CSLCs, potentially suppressing the development of acquired drug resistance. Taken together, our results demonstrate an unreported finding that EA inhibits CSLCs by targeting mitochondrial function and triggering apoptosis. Thus, EA can be used either alone or in combination with other chemotherepeutic drugs for the management of cancer.Keywords
Funding Information
- Council of Scientific and Industrial Research, India (MLP-138)
- Ministry of AYUSH, Government of India (1306/2022-23)
- CSIR - Indian Institute of Chemical Biology (P07)
This publication has 48 references indexed in Scilit:
- Mfn2-mediated mitochondrial fusion promotes autophagy and suppresses ovarian cancer progression by reducing ROS through AMPK/mTOR/ERK signalingCellular and Molecular Life Sciences, 2022
- Cancer statistics for the year 2020: An overviewInternational Journal of Cancer, 2021
- Ellagic acid ameliorates cisplatin toxicity in chemically induced colon carcinogenesisMolecular and Cellular Biochemistry, 2018
- Exploring the potential of Mangifera indica leaves extract versus mangiferin for therapeutic applicationAgriculture and Natural Resources, 2018
- Activation of apoptosis signalling pathways by reactive oxygen speciesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2016
- Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: A systematic reviewDrug Resistance Updates, 2011
- ABC Transporters, Drug Resistance, and Cancer Stem CellsJournal of Mammary Gland Biology and Neoplasia, 2009
- Hit 'Em Where They Live: Targeting the Cancer Stem Cell NicheCancer Cell, 2007
- DNA-PK phosphorylates histone H2AX during apoptotic DNA fragmentation in mammalian cellsDNA Repair, 2006
- NMR assignments of ellagic acid derivativesMagnetic Resonance in Chemistry, 1999